Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
Some pancreatic cancer patients are seeing a nearly double rate of survival after using a new drug, according to new research. Dr. Harsh Singh, a program director at the MGB Cancer Institute, joins with more details.
Some pancreatic cancer patients are seeing a nearly double rate of survival after using a new drug, according to new research. Dr. Harsh Singh, a program director at the MGB Cancer Institute, joins with more details.
Some pancreatic cancer patients are seeing a nearly double rate of survival after using a new drug, according to new research. Dr. Harsh Singh, a program director at the MGB Cancer Institute, joins with more details.
The full story continues on CBS News.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.